Recurrence of atrial tachyarrhythmias in implantable cardioverter- defibrillator recipients

PACE - Pacing and Clinical Electrophysiology

Volumn 28, Issue 10, 2005, Pages 1047-1051

  Darbar, Dawood ^a   Warman, Eduardo N ^b   Hammill, Stephen C ^a   Friedman, Paul A ^a  

^a MAYO CLINIC   (United States)

^b MEDTRONIC INC   (United States)

Author keywords

Atrial arrhythmia; Implantable cardioverter defibrillator; Therapy

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; SOTALOL;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DEFIBRILLATOR; DIAGNOSTIC TEST; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT IDENTIFICATION; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT INDICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART ATRIUM; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TACHYCARDIA;

AGED; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART ATRIA; HUMANS; MALE; RECURRENCE; TACHYCARDIA;

EID: 33645249774     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2005.00222.x     Document Type: Article

References (9)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995 155 : 469 473.
2. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 1998 114 (Suppl 579 589.
3. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study. JAMA 1994 271 : 840 844.
4. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, for the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002 347 : 1825 1833.
5. Friedman PA, Dijkman B, Warman EN, Xia HA, Mehra R, Stanton MS, Hammill SC. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001 104 : 1023 1028.
6. Adler SW II., Wolpert C, Warman EN, Musley SK, Koehler JL, Euler DE. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 2001 104 : 887 892.
7. Gillis AM, Unterberg-Buchwald C, Schmidinger H, Massimo S, Wolfe K, Kavaney DJ, Otterness MF, Hohnloser SH, for the GEM III AT Worldwide Investigators. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-debrillator. J Am Coll Cardiol 2002 40 : 1653 1659.
8. Best PJ, Hayes DL, Stanton MS. The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1999 22 : 79 85.
9. Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S, Scharf C, Lai SW, Greenstein R, Pelosi F Jr., Strickberger SA, Morady F. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002 105 : 1077 1081.